These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7635563)

  • 1. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.
    Yamada N; Kato M; Yamashita H; Nistér M; Miyazono K; Heldin CH; Funa K
    Int J Cancer; 1995 Aug; 62(4):386-92. PubMed ID: 7635563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
    Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
    J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
    Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
    Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
    Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
    Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1.
    Piek E; Westermark U; Kastemar M; Heldin CH; van Zoelen EJ; Nistér M; Ten Dijke P
    Int J Cancer; 1999 Mar; 80(5):756-63. PubMed ID: 10048979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
    Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K
    Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.
    Nørgaard P; Damstrup L; Rygaard K; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1994 May; 69(5):802-8. PubMed ID: 8180008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Nagasaka M; Isoe S; Nakano S; Nukui H
    Neurol Med Chir (Tokyo); 1995 Jul; 35(7):423-30. PubMed ID: 7477684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.
    Liu P; Menon K; Alvarez E; Lu K; Teicher BA
    Int J Oncol; 2000 Mar; 16(3):599-610. PubMed ID: 10675495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Lang S; Kato M; Oefelein MG; Miyazono K; Nemeth JA; Kozlowski JM; Lee C
    Clin Cancer Res; 1996 Aug; 2(8):1255-61. PubMed ID: 9816295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
    Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
    Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
    Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
    Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue.
    Kai T; Taketazu F; Kawakami M; Shimanuki K; Yamada S; Miyazono K; Kato M; Miyata M
    Jpn J Cancer Res; 1996 Mar; 87(3):296-304. PubMed ID: 8613433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.